Safety study of RN5681 in healthy volunteers
Part of Hormones & metabolism clinical trials.
This trial tests a new drug called RN5681 to see if it is safe and how the body processes it. It is for healthy people with certain cholesterol levels and may help people with high cholesterol or heart risk in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old with a body mass index (BMI) between 18 and 35.
- Your fasting LDL (bad cholesterol) must be at least 70 mg/dL for most groups, or at least 100 mg/dL for a special group.
- Your fasting Lp(a) (a type of cholesterol linked to heart disease) must be at least 25 nmol/L for most groups, or at least 100 nmol/L for a special group.
- Your fasting triglycerides (another blood fat) must be less than 400 mg/dL.
- You have no significant liver or kidney problems, and your liver enzymes are not too high.
- You have not used any gene therapy, special cholesterol-lowering drugs, or smoked more than 2 cigarettes a day in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
Hear when a new High Cholesterol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.